Cargando…

Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study

The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Defante Ferreto, Lirane Elize, Guedes, Stephanny, Braz Pauli, Fernando, Soligo Rovani, Samyra, Aní Caovilla Follador, Franciele, Paula Vieira, Ana, Himovski Torres, Renata, Colares Coelho, Harnoldo, Welter Wendt, Guilherme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312944/
https://www.ncbi.nlm.nih.gov/pubmed/34310633
http://dx.doi.org/10.1371/journal.pone.0255173
_version_ 1783729230933131264
author Defante Ferreto, Lirane Elize
Guedes, Stephanny
Braz Pauli, Fernando
Soligo Rovani, Samyra
Aní Caovilla Follador, Franciele
Paula Vieira, Ana
Himovski Torres, Renata
Colares Coelho, Harnoldo
Welter Wendt, Guilherme
author_facet Defante Ferreto, Lirane Elize
Guedes, Stephanny
Braz Pauli, Fernando
Soligo Rovani, Samyra
Aní Caovilla Follador, Franciele
Paula Vieira, Ana
Himovski Torres, Renata
Colares Coelho, Harnoldo
Welter Wendt, Guilherme
author_sort Defante Ferreto, Lirane Elize
collection PubMed
description The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (M(age) = 32.58±10.18) from eleven high-security prisons located in the State of Paraná, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0–2.5) and 2.7% (95% CI: 1.0–2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15–66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47–10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58–11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61–10.07), criminal recidivism (OR = 2.58, 95% CI 1.02–6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36–15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution.
format Online
Article
Text
id pubmed-8312944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83129442021-07-31 Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study Defante Ferreto, Lirane Elize Guedes, Stephanny Braz Pauli, Fernando Soligo Rovani, Samyra Aní Caovilla Follador, Franciele Paula Vieira, Ana Himovski Torres, Renata Colares Coelho, Harnoldo Welter Wendt, Guilherme PLoS One Research Article The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (M(age) = 32.58±10.18) from eleven high-security prisons located in the State of Paraná, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0–2.5) and 2.7% (95% CI: 1.0–2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15–66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47–10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58–11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61–10.07), criminal recidivism (OR = 2.58, 95% CI 1.02–6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36–15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution. Public Library of Science 2021-07-26 /pmc/articles/PMC8312944/ /pubmed/34310633 http://dx.doi.org/10.1371/journal.pone.0255173 Text en © 2021 Defante Ferreto et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Defante Ferreto, Lirane Elize
Guedes, Stephanny
Braz Pauli, Fernando
Soligo Rovani, Samyra
Aní Caovilla Follador, Franciele
Paula Vieira, Ana
Himovski Torres, Renata
Colares Coelho, Harnoldo
Welter Wendt, Guilherme
Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title_full Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title_fullStr Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title_full_unstemmed Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title_short Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study
title_sort seroprevalence and associated factors of hiv and hepatitis c in brazilian high-security prisons: a state-wide epidemiological study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312944/
https://www.ncbi.nlm.nih.gov/pubmed/34310633
http://dx.doi.org/10.1371/journal.pone.0255173
work_keys_str_mv AT defanteferretoliraneelize seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT guedesstephanny seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT brazpaulifernando seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT soligorovanisamyra seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT anicaovillafolladorfranciele seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT paulavieiraana seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT himovskitorresrenata seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT colarescoelhoharnoldo seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT welterwendtguilherme seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy